Health Systems Expand In-House Specialty Pharmacy Operations Amid 340B Restrictions
Health systems are increasingly establishing their own specialty pharmacy operations in response to tightening reimbursement and manufacturer restrictions on 340B contract pharmacy arrangements. Hospitals and health systems now represent the fastest-growing segment of direct participants in the specialty pharmacy market. The shift is driven by both revenue generation goals and manufacturers' evolving 340B policies that limit contract pharmacy access. This infrastructure buildout allows health systems to capture specialty drug dispensing margins and maintain access to 340B savings despite manufacturer restrictions.
Health system-owned specialty pharmacies may compete with MCO pharmacy benefit management strategies and alter specialty drug distribution channels that affect network adequacy, utilization management, and total cost of care arrangements.
Pharmacy · Managed Care
You might also like